CC Small or few human trials. Promising, not proven. How we grade →Animal study (ITP) · Genetically diverse mice at three sites, three doses
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
R Miller, D Harrison, C Astle, E Fernandez, K Flurkey, M Han et al. Aging Cell. 2014.
- In plain language
- At a dose three times higher than earlier ITP tests, rapamycin raised median lifespan by 23% in males and 26% in females; females gained more at every dose.
- Limits
- Mouse data; blood drug levels differed by sex.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Rapamycin and mTOR: strong mouse lifespan data, early human trials
- Source
- doi.org/10.1111/acel.12194 · PubMed 24341993 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.